Real-time Glaucoma Medication Adherence
| Status: | Terminated |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/9/2018 |
| Start Date: | May 8, 2017 |
| End Date: | July 15, 2018 |
Leveraging Real-Time Medication Use Monitoring to Improve Adherence in Adults With Glaucoma
This study will evaluate the effectiveness of real-time data collected on patients taking
topical medication to treat glaucoma. Patients will be randomized to two groups, the first of
which will only use the study device to take their medication, while the second will use the
study device and receive on-demand reminder messages, when necessary.
topical medication to treat glaucoma. Patients will be randomized to two groups, the first of
which will only use the study device to take their medication, while the second will use the
study device and receive on-demand reminder messages, when necessary.
Adherence to topical medications to treat glaucoma remains sub optimal; however, our
understanding of this behavior remains limited due to biased measures of medication use. The
Kali Drop device is a potential improvement in our ability to capture medication use in
patients using dropper bottles by precisely capturing the amount dispensed in real-time.
Moreover, such technology creates data that can be leveraged into driving behavior change
using connected mobile technology in order to improve adherence and, ultimately, health
outcomes. While evidence suggests that reminders may improve adherence to glaucoma
medications, the power of doing so using real-time data has yet to be explored. This study
will compare simple monitoring of patients to those who are being monitored and who receive
reminder messages when the system determines one is necessary due to a missed dose.
understanding of this behavior remains limited due to biased measures of medication use. The
Kali Drop device is a potential improvement in our ability to capture medication use in
patients using dropper bottles by precisely capturing the amount dispensed in real-time.
Moreover, such technology creates data that can be leveraged into driving behavior change
using connected mobile technology in order to improve adherence and, ultimately, health
outcomes. While evidence suggests that reminders may improve adherence to glaucoma
medications, the power of doing so using real-time data has yet to be explored. This study
will compare simple monitoring of patients to those who are being monitored and who receive
reminder messages when the system determines one is necessary due to a missed dose.
Inclusion Criteria:
- 18 years of age and older
- Glaucoma diagnosis
- Prescription for a prostaglandin indicated for glaucoma
- Nonadherent (MPR<80%) in the last 3 months according to pharmacy records
- Owns and operates a mobile phone and willing to receive periodic reminder messages
Exclusion Criteria:
- Existing chronic eye condition in addition to glaucoma
- Scheduled for eye surgery in the next 90 days
- Prescription for a medication that will not fit in the device
- Non-English speaking
We found this trial at
7
sites
Click here to add this to my saved trials
2604 Peach Orchard Road
Augusta, Georgia 30906
Augusta, Georgia 30906
Principal Investigator: Ashley London, PharmD
Phone: 706-863-3456
Click here to add this to my saved trials
119 North Main Street
Blackwell, Oklahoma 74631
Blackwell, Oklahoma 74631
Principal Investigator: Clark Hutton, PharmD
Phone: 580-363-2137
Click here to add this to my saved trials
14101 North Eastern Avenue
Edmond, Oklahoma 73013
Edmond, Oklahoma 73013
Principal Investigator: Phong Hoang, PharmD
Phone: 405-562-1800
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
103 East State Highway 152
Mustang, Oklahoma 73064
Mustang, Oklahoma 73064
Principal Investigator: Selma Alami, PharmD
Phone: 405-256-0555
Click here to add this to my saved trials